| David E North, MD | |
|
1910 Carbonado Rd, Oskaloosa, IA 52577-2424 | |
| (641) 676-3366 | |
| (641) 673-3366 |
| Full Name | David E North |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 1910 Carbonado Rd, Oskaloosa, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568450849 | NPI | - | NPPES |
| 71588 | Other | IA | WELLMARK BCBS |
| 1187377 | Medicaid | IA | |
| P00604766 | Other | IA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 32784 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caregivers Home Health Of Chariton | Chariton, IA | Home health agency |
| Mahaska Health Partnership | Oskaloosa, IA | Hospital |
| Oskaloosa Care Center | Oskaloosa, IA | Nursing home |
| Crystal Heights Care Center | Oskaloosa, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mahaska County Hospital | 2769388677 | 55 |
News Archive
A therapy that liberates the immune system to attack cancer cells drove Hodgkin lymphoma (HL) into complete or partial remission in fully 87 percent of patients with resistant forms of the disease who participated in an early-phase clinical trial, investigators at Dana-Farber Cancer Institute and partnering institutions report in a study published today in the New England Journal of Medicine and simultaneously presented at the annual meeting of the American Society of Hematology in San Francisco.
The authors explain this detour by showing that an attractant protein that normally directs T cells into the gut is aberrantly produced in the liver during PSC. T cells expressing the receptor for the protein are thus re-routed to the liver
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
Hormone replacement therapy (HRT) has been shown to reduce many cardiovascular disease (CVD) risk factors, but many women have stopped using HRT due to reports from the Women's Health Initiative that HRT may increase the risk of breast cancer and heart disease.
Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.
› Verified 1 days ago
| Entity Name | Mahaska County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639159304 PECOS PAC ID: 2769388677 Enrollment ID: O20041202000965 |
News Archive
A therapy that liberates the immune system to attack cancer cells drove Hodgkin lymphoma (HL) into complete or partial remission in fully 87 percent of patients with resistant forms of the disease who participated in an early-phase clinical trial, investigators at Dana-Farber Cancer Institute and partnering institutions report in a study published today in the New England Journal of Medicine and simultaneously presented at the annual meeting of the American Society of Hematology in San Francisco.
The authors explain this detour by showing that an attractant protein that normally directs T cells into the gut is aberrantly produced in the liver during PSC. T cells expressing the receptor for the protein are thus re-routed to the liver
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
Hormone replacement therapy (HRT) has been shown to reduce many cardiovascular disease (CVD) risk factors, but many women have stopped using HRT due to reports from the Women's Health Initiative that HRT may increase the risk of breast cancer and heart disease.
Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.
› Verified 1 days ago
| Entity Name | Mahaska County Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1356320659 PECOS PAC ID: 2769388677 Enrollment ID: O20061104000235 |
News Archive
A therapy that liberates the immune system to attack cancer cells drove Hodgkin lymphoma (HL) into complete or partial remission in fully 87 percent of patients with resistant forms of the disease who participated in an early-phase clinical trial, investigators at Dana-Farber Cancer Institute and partnering institutions report in a study published today in the New England Journal of Medicine and simultaneously presented at the annual meeting of the American Society of Hematology in San Francisco.
The authors explain this detour by showing that an attractant protein that normally directs T cells into the gut is aberrantly produced in the liver during PSC. T cells expressing the receptor for the protein are thus re-routed to the liver
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
Hormone replacement therapy (HRT) has been shown to reduce many cardiovascular disease (CVD) risk factors, but many women have stopped using HRT due to reports from the Women's Health Initiative that HRT may increase the risk of breast cancer and heart disease.
Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David E North, MD Po Box 71602, Clive, IA 50325-0602 Ph: (515) 243-2057 | David E North, MD 1910 Carbonado Rd, Oskaloosa, IA 52577-2424 Ph: (641) 676-3366 |
News Archive
A therapy that liberates the immune system to attack cancer cells drove Hodgkin lymphoma (HL) into complete or partial remission in fully 87 percent of patients with resistant forms of the disease who participated in an early-phase clinical trial, investigators at Dana-Farber Cancer Institute and partnering institutions report in a study published today in the New England Journal of Medicine and simultaneously presented at the annual meeting of the American Society of Hematology in San Francisco.
The authors explain this detour by showing that an attractant protein that normally directs T cells into the gut is aberrantly produced in the liver during PSC. T cells expressing the receptor for the protein are thus re-routed to the liver
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
Hormone replacement therapy (HRT) has been shown to reduce many cardiovascular disease (CVD) risk factors, but many women have stopped using HRT due to reports from the Women's Health Initiative that HRT may increase the risk of breast cancer and heart disease.
Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.
› Verified 1 days ago
Matthew D. Olson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1229 C Ave E, Oskaloosa, IA 52577 Phone: 641-672-3100 Fax: 641-672-3111 | |
Shawn Michael Richmond, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 410 N 12th St, Oskaloosa, IA 52577 Phone: 641-672-3360 Fax: 641-672-2258 | |
Charles R Argo, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 410 N 12th St, Suite 300, Oskaloosa, IA 52577 Phone: 641-672-2571 | |
Anna Marie Throckmorton, ARNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1229 C Ave E, Oskaloosa, IA 52577 Phone: 641-672-3160 | |
Tony R Kunz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 410 N 12th St, Suite 300, Oskaloosa, IA 52577 Phone: 641-672-2571 | |
Anne K Whitis, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 410 N 12th St, Suite 300, Oskaloosa, IA 52577 Phone: 641-672-2571 | |
Mark Zacharjasz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1229 C Ave E, Oskaloosa, IA 52577 Phone: 641-672-3100 |